MedTrace Logo

Cervical Priming Before Dilation & Evacuation

NCT01597726 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2013-11-07

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of buccal misoprostol cervical priming to laminaria priming among women undergoing D\&E at 13-20 weeks gestation in the Western Cape Province, South Africa

Conditions

  • Abortion, Induced

Interventions

DRUG

Misoprostol

Misoprostol 400 mcg administered buccally approximately 3-6 hours prior to D\&E, repeated once 3 hours after the first dose if needed

DEVICE

Laminaria

Laminaria tents inserted into the cervix 18 to 24 hours prior to D\&E

Sponsors & Collaborators

  • University of Cape Town

    collaborator OTHER

  • Tygerberg Hospital

    collaborator UNKNOWN

  • Safe Abortion Action Fund of the International Planned Parenthood Federation

    collaborator UNKNOWN

  • Society of Family Planning

    collaborator OTHER

  • Ibis Reproductive Health

    lead OTHER

Principal Investigators

  • Judy Kluge, MBChB · Tygerberg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01597726 on ClinicalTrials.gov